Rotarix Suspension 1.5ml

About Rotarix Suspension 1.5ml

Rotarix Suspension 1.5ml Uses

• Prevention of rotavirus gastroenteritis in infants
• Protection against severe watery diarrhea caused by rotavirus
• Reduction of rotavirus related hospital admissions in infants
• Part of the routine infant immunization schedule

Rotarix Suspension 1.5ml Benefits

• Reduces the risk of severe dehydration from rotavirus diarrhea
• Provides protection against multiple common rotavirus strains
• Given orally, so there is no injection discomfort for the infant
• Two dose primary series completes protection early in infancy
• Long standing global safety record in infant immunization programs

What Experts Say

Rotarix uses a live, attenuated human rotavirus strain that replicates within the lining of the gut after an oral dose, prompting the infant's immune system to build protective antibodies in a way that mirrors natural infection without causing severe illness.

The two dose schedule beginning in early infancy is timed to the age window when rotavirus disease tends to be most severe, since a developing immune system needs repeated antigen exposure to build durable protection before the period of highest natural exposure risk.

Before each dose, clinicians review the infant's health history for prior bowel surgery, congenital gastrointestinal malformation, immune deficiency or signs of acute illness, since rotavirus remains one of the leading causes of severe dehydrating diarrhea and hospital admission in young children worldwide, which gives vaccination meaningful preventive weight in routine pediatric care.

Drug Class

• Live Attenuated Viral Vaccine

Rotarix Suspension 1.5ml formula

• Live Attenuated Human Rotavirus Vaccine (RIX4414 Strain)

Available forms

• Suspension

How to use Rotarix Suspension 1.5ml?

• Administered only by a doctor or trained healthcare provider, never given at home
• Given orally directly into the infant's mouth using the pre filled applicator
• First dose usually given between 6 and 15 weeks of age
• Second dose given at least 4 weeks after the first dose
• Full course generally completed before the infant reaches 24 weeks of age
• Not for reconstitution, injection or self administration by a parent

Drug Interactions

• Other Live Vaccines: Can generally be co-administered with other routine infant vaccines given at the same visit.
• Immunosuppressive Therapy: Reduced vaccine effectiveness is expected in infants receiving immunosuppressive treatment.
• Blood Products or Immunoglobulins: May reduce the immune response if given close together with the vaccine.

Risks and warnings

• Intussusception Risk: A small increased risk of bowel intussusception has been reported, mainly within seven days of dosing.
• Immunocompromised Infants: Use caution in infants with weakened immune systems or a family history of immunodeficiency.
• Prior Bowel Surgery: Avoid in infants with a history of intussusception or an uncorrected bowel malformation.
• Acute Illness: Postpone vaccination if the infant has moderate to severe acute illness or fever.
• Premature Infants: Use only after physician evaluation of gestational age and overall health.

Rotarix Suspension 1.5ml Side Effects

• Irritability or fussiness
• Mild fever
• Loss of appetite
• Diarrhea
• Vomiting
• Mild abdominal discomfort or gas
• Rare risk of intussusception

Storage Conditions

• Refrigerate at 2°C to 8°C at all times, from delivery until use.
• Protect the applicator from light by keeping it in its original carton.
• Do not freeze the vaccine or store it in the freezer compartment.
• Use the vaccine immediately once the applicator cap is removed.
• Keep out of reach of children and unauthorized handling.